Developer docs
API playgroundTry for free, no card

Search company profiles

American Radiolabeled Chemicals

Full company profile

uuid00257he

Namestring
American Radiolabeled Chemicals
Legal namestring
American Radiolabeled Chemicals, Inc
Websiteurl
arcincusa.com
Company typeenum
Private
Founded yearint
1983
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersSt Louis, United States
HQ citystring
St Louis
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
radiolabeled chemicals, carbon-14 compounds, tritium labeling, custom radiochemical synthesis, life science reagents
Industry1 code
1Radioisotope Production (Reactor/Cyclotron/Gamma)
CodeHLAIAGADPrimaryYes
NAICS code1 code
  • In-Vitro Diagnostic Substance Manufacturing325413
SIC code1 code
  • Chemicals & Allied Products2800
Product category
Radiolabeled Chemicals & Radiochemical Reagents
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1Radiolabeled Compound Sales
TypeOne Time License
Description

Sale of radiolabeled chemicals including Carbon-14, Tritium, Phosphorus-32, Phosphorus-33, Sulfur-35, and other radioisotopes. Products are sold in various quantities (µCi, mCi) with specific activities and concentrations. Pricing is quote-based for most products.

arcincusa.com
2Custom Synthesis Services
TypeProfessional Services
Description

Custom radiochemical synthesis services utilizing Carbon-14 and Tritium, with limited basis support for Phosphorus-33, Sulfur-35, and selected stable isotopes. This is a specialized service requiring expertise in radiochemistry.

arcincusa.com
3Unlabeled Compound Sales
TypeOne Time License
Description

Sale of unlabeled chemical compounds that complement the radiolabeled product portfolio, serving as reference materials and starting compounds for research.

arcincusa.com
Marketing channels1 record

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Supply Chain, Operations, Personnel, Technology or R&D, Infrastructure, Marketing or Sales
Pricing details1 tier
1Standard product pricing based on compound type, activity level, and quantity
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Products are priced per unit (µCi, mCi) based on specific activity, compound complexity, and isotope type. Login-based pricing available for registered accounts.

arcincusa.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

ARC manufactures and supplies radiolabeled and unlabeled chemicals—predominantly Carbon-14 and Tritium (Hydrogen-3) labeled compounds, plus other radioisotopes such as Phosphorus-32/33, Sulfur-35, Iodine-125, Chlorine-36, Chromium-51, Calcium-45, Iron-55/59, Sodium-22, Strontium-85, and Zinc-65—alongside stable isotopes, unlabeled reference compounds, and autoradiography standards for life science research. The company complements its catalog of 4,000+ compounds with custom radiochemical synthesis services utilizing Carbon-14 and Tritium, with limited basis support for Phosphorus-33, Sulfur-35, and selected stable isotopes.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

American Radiolabeled Chemicals (ARC) is a supplier of radiolabeled and unlabeled chemicals for life science research. Founded in 1983, the company offers a catalog of more than 4,000 compounds with over 85% exclusively available through ARC. The core product portfolio centers on Carbon-14 and Tritium (Hydrogen-3) labeled compounds, supplemented by a range of other radioisotopes including Phosphorus-32, Phosphorus-33, Iodine-125, Sulfur-35, Chlorine-36, Chromium-51, Calcium-45, Iron-55, Iron-59, Sodium-22, Strontium-85, and Zinc-65. The company also provides autoradiography standards for Carbon-14, Iodine-125, and Tritium, stable isotopes, and unlabeled compounds. ARC complements its product offerings with custom radiochemical synthesis services utilizing Carbon-14 and Tritium, with limited support for Phosphorus-33, Sulfur-35, and selected stable isotopes. New products are continuously added throughout the year and integrated into their searchable online database.

Product and service18 records
1Carbon-14 (14C) Labeled Compounds
CategoryRadiochemicals
Description

Over 1,400 Carbon-14 radiolabeled chemical compounds including amino acids, fatty acids, pharmaceuticals, and environmental compounds for life science research.

2Tritium (Hydrogen-3, 3H) Labeled Compounds
CategoryRadiochemicals
Description

Extensive portfolio of Tritium-labeled compounds for research applications, complementing the Carbon-14 range.

3Autoradiography Standards (Carbon-14, Iodine-125, Tritium)
CategoryAutoradiography Standards
Description

Standards for autoradiography including Carbon-14, Iodine-125, and Tritium standards for calibration and reference applications.

4Phosphorus-32 Labeled Compounds
CategoryRadiochemicals
Description

Phosphorus-32 radiolabeled compounds for life science research applications.

5Phosphorus-33 Labeled Compounds
CategoryRadiochemicals
Description

Phosphorus-33 radiolabeled compounds for life science research applications.

6Iodine-125 Radiolabeled Compounds
CategoryRadiochemicals
Description

Iodine-125 radiolabeled compounds and standards for life science research applications.

7Sulfur-35 Radiolabeled Compounds
CategoryRadiochemicals
Description

Sulfur-35 radiolabeled compounds for life science research applications.

8Chlorine-36 Radionuclide Products
CategoryRadiochemicals
Description

Chlorine-36 radionuclide available as hydrogen chloride, potassium chloride, and sodium chloride forms for research applications.

9Chromium-51 Radionuclide (Sodium Chromate)
CategoryRadiochemicals
Description

Chromium-51 radionuclide as sodium chromate for life science research applications.

10Calcium-45 Radiolabeled Compounds
CategoryRadiochemicals
Description

Calcium-45 radiolabeled compounds for life science research applications.

11Iron-55 Radiolabeled Compounds
CategoryRadiochemicals
Description

Iron-55 radiolabeled compounds for life science research applications.

12Iron-59 Radiolabeled Compounds
CategoryRadiochemicals
Description

Iron-59 radiolabeled compounds for life science research applications.

13Sodium-22 Radiolabeled Compounds
CategoryRadiochemicals
Description

Sodium-22 radiolabeled compounds for life science research applications.

14Strontium-85 Radiolabeled Compounds
CategoryRadiochemicals
Description

Strontium-85 radiolabeled compounds for life science research applications.

15Zinc-65 Radiolabeled Compounds
CategoryRadiochemicals
Description

Zinc-65 radiolabeled compounds for life science research applications.

16Stable Isotopes
CategoryStable Isotopes
Description

Non-radioactive stable isotope products for life science research applications.

17Unlabeled Compounds
CategoryUnlabeled Compounds
Description

Non-radiolabeled chemical compounds serving as reference materials and starting materials for radiolabeling and research.

18Custom Radiochemical Synthesis Services
CategoryCustom Synthesis Services
Description

Custom radiochemical synthesis services using Carbon-14 and Tritium, with limited support for Phosphorus-33, Sulfur-35, and selected stable isotopes for specialized research projects.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Recent move4 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Global leader in nuclear medicine with a broad radiopharmaceutical portfolio. Comparable in radiochemistry domain but focused on clinical/therapeutic isotopes rather than research reagents.

TypeDirect peer
Description

Custom radiolabeled synthesis and radiochemistry services arm of Pharmaron. Direct peer for ARC's custom synthesis business serving pharma ADME and metabolism studies.

TypeBroad incumbent
Description

Large life-sciences tools and reagents platform with radiolabeled and radiochemical offerings (e.g., through NEN brand heritage). Comparable at the broad category level but operates at materially larger scale and breadth than ARC.

TypeEmerging player
Description

Specialty radiochemistry contract manufacturer focused on custom radiolabeled compounds and radiopharmaceutical development. Comparable as a niche, custom-synthesis-oriented peer.

TypeBroad incumbent
Description

Established radiopharmaceutical/nuclear medicine company. Comparable in the broader nuclear medicine domain, though focused on clinical imaging rather than research-grade compounds.

TypeEmerging player
Description

Growing radiopharmaceutical company with expanding isotope and therapeutic capabilities. Comparable as a participant in the broader nuclear-medicine value chain, though focused on clinical rather than research use.

TypeDirect peer
Description

German manufacturer of radioactive and stable isotope-labeled compounds for medical and research use. Comparable to ARC as a specialized radiochemical supplier with similar isotope coverage.

TypeDirect peer
Description

US-based manufacturer of radiolabeled compounds (Carbon-14, Tritium) for life science research, with custom synthesis services. Directly competes with ARC in catalog breadth and target customer base.

TypeDirect peer
Description

Specialty manufacturer of radiolabeled chemicals and stable isotope-labeled compounds for research. Closely comparable to ARC in product category, scale, and research customer focus.

TypeBroad incumbent
Description

Major incumbent in nuclear medicine, radiopharmaceuticals, and life-sciences tools. Overlaps with ARC at the broader radiochemistry and life-science research category level.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Subsidiaries2 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

American Radiolabeled Chemicals

Radiolabeled Chemicals & Radiochemical Reagentsarcincusa.com

American Radiolabeled Chemicals firmographics

Firmographics
Name
American Radiolabeled Chemicals
Legal name
American Radiolabeled Chemicals, Inc
Website
https://arcincusa.com
Company type
Private
Founded year
1983
Operating status
Operating
Headcount range
11–50 employees
Ownership category
akta.pro rank

American Radiolabeled Chemicals industry classification

Industry
Product category
Radiolabeled Chemicals & Radiochemical Reagents
NAICS
In-Vitro Diagnostic Substance Manufacturing (325413)
SIC
Chemicals & Allied Products (2800)
akta.pro primary industry
Radioisotope Production (Reactor/Cyclotron/Gamma) (HLAIAGAD)

Keywords

  • Radiolabeled chemicals
  • Carbon-14 compounds
  • Tritium labeling
  • Custom radiochemical synthesis
  • Life science reagents

Where American Radiolabeled Chemicals is headquartered

Location

Headquarters

HQ city
St Louis
HQ country
United States
HQ region
North America

Offices3 records

Markets served

American Radiolabeled Chemicals business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Operations, Personnel, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

  1. Radiolabeled Compound Sales: Sale of radiolabeled chemicals including Carbon-14, Tritium, Phosphorus-32, Phosphorus-33, Sulfur-35, and other radioisotopes. Products are sold in various quantities (µCi, mCi) with specific activities and concentrations. Pricing is quote-based for most products.
  2. Custom Synthesis Services: Custom radiochemical synthesis services utilizing Carbon-14 and Tritium, with limited basis support for Phosphorus-33, Sulfur-35, and selected stable isotopes. This is a specialized service requiring expertise in radiochemistry.
  3. Unlabeled Compound Sales: Sale of unlabeled chemical compounds that complement the radiolabeled product portfolio, serving as reference materials and starting compounds for research.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goStandard product pricing based on compound type, activity level, and quantity

Go-to-market motion1 record

Distribution channels1 record

Marketing channels1 record

American Radiolabeled Chemicals product offering

Product offering

Core offering

ARC manufactures and supplies radiolabeled and unlabeled chemicals—predominantly Carbon-14 and Tritium (Hydrogen-3) labeled compounds, plus other radioisotopes such as Phosphorus-32/33, Sulfur-35, Iodine-125, Chlorine-36, Chromium-51, Calcium-45, Iron-55/59, Sodium-22, Strontium-85, and Zinc-65—alongside stable isotopes, unlabeled reference compounds, and autoradiography standards for life science research. The company complements its catalog of 4,000+ compounds with custom radiochemical synthesis services utilizing Carbon-14 and Tritium, with limited basis support for Phosphorus-33, Sulfur-35, and selected stable isotopes.

Product overview

American Radiolabeled Chemicals (ARC) is a supplier of radiolabeled and unlabeled chemicals for life science research. Founded in 1983, the company offers a catalog of more than 4,000 compounds with over 85% exclusively available through ARC. The core product portfolio centers on Carbon-14 and Tritium (Hydrogen-3) labeled compounds, supplemented by a range of other radioisotopes including Phosphorus-32, Phosphorus-33, Iodine-125, Sulfur-35, Chlorine-36, Chromium-51, Calcium-45, Iron-55, Iron-59, Sodium-22, Strontium-85, and Zinc-65. The company also provides autoradiography standards for Carbon-14, Iodine-125, and Tritium, stable isotopes, and unlabeled compounds. ARC complements its product offerings with custom radiochemical synthesis services utilizing Carbon-14 and Tritium, with limited support for Phosphorus-33, Sulfur-35, and selected stable isotopes. New products are continuously added throughout the year and integrated into their searchable online database.

Differentiator

Problem solved

Functional benefit

Products and services

  • Carbon-14 (14C) Labeled Compounds Over 1,400 Carbon-14 radiolabeled chemical compounds including amino acids, fatty acids, pharmaceuticals, and environmental compounds for life science research.
  • Tritium (Hydrogen-3, 3H) Labeled Compounds Extensive portfolio of Tritium-labeled compounds for research applications, complementing the Carbon-14 range.
  • Autoradiography Standards (Carbon-14, Iodine-125, Tritium) Standards for autoradiography including Carbon-14, Iodine-125, and Tritium standards for calibration and reference applications.
  • Phosphorus-32 Labeled Compounds Phosphorus-32 radiolabeled compounds for life science research applications.
  • Phosphorus-33 Labeled Compounds Phosphorus-33 radiolabeled compounds for life science research applications.
  • Iodine-125 Radiolabeled Compounds Iodine-125 radiolabeled compounds and standards for life science research applications.
  • Sulfur-35 Radiolabeled Compounds Sulfur-35 radiolabeled compounds for life science research applications.
  • Chlorine-36 Radionuclide Products Chlorine-36 radionuclide available as hydrogen chloride, potassium chloride, and sodium chloride forms for research applications.
  • Chromium-51 Radionuclide (Sodium Chromate) Chromium-51 radionuclide as sodium chromate for life science research applications.
  • Calcium-45 Radiolabeled Compounds Calcium-45 radiolabeled compounds for life science research applications.
  • Iron-55 Radiolabeled Compounds Iron-55 radiolabeled compounds for life science research applications.
  • Iron-59 Radiolabeled Compounds Iron-59 radiolabeled compounds for life science research applications.
  • Sodium-22 Radiolabeled Compounds Sodium-22 radiolabeled compounds for life science research applications.
  • Strontium-85 Radiolabeled Compounds Strontium-85 radiolabeled compounds for life science research applications.
  • Zinc-65 Radiolabeled Compounds Zinc-65 radiolabeled compounds for life science research applications.
  • Stable Isotopes Non-radioactive stable isotope products for life science research applications.
  • Unlabeled Compounds Non-radiolabeled chemical compounds serving as reference materials and starting materials for radiolabeling and research.
  • Custom Radiochemical Synthesis Services Custom radiochemical synthesis services using Carbon-14 and Tritium, with limited support for Phosphorus-33, Sulfur-35, and selected stable isotopes for specialized research projects.

Companies that use American Radiolabeled Chemicals

Customer profile

Segments1 record

Ideal customer profiles1 record

American Radiolabeled Chemicals technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

American Radiolabeled Chemicals partnerships and signals

Strategic signal

Scale indicators4 records

Recent moves4 records

Expansion highlights4 records

American Radiolabeled Chemicals competitors and assessment

Company assessment

Broad incumbents

  • Curium Pharma: Global leader in nuclear medicine with a broad radiopharmaceutical portfolio. Comparable in radiochemistry domain but focused on clinical/therapeutic isotopes rather than research reagents.
  • Revvity (formerly PerkinElmer Life Sciences): Large life-sciences tools and reagents platform with radiolabeled and radiochemical offerings (e.g., through NEN brand heritage). Comparable at the broad category level but operates at materially larger scale and breadth than ARC.
  • Lantheus Holdings: Established radiopharmaceutical/nuclear medicine company. Comparable in the broader nuclear medicine domain, though focused on clinical imaging rather than research-grade compounds.
  • GE HealthCare / Cytiva: Major incumbent in nuclear medicine, radiopharmaceuticals, and life-sciences tools. Overlaps with ARC at the broader radiochemistry and life-science research category level.

Direct peers

  • Quotient Bioresearch (Pharmaron Radiolabeled Chemistry): Custom radiolabeled synthesis and radiochemistry services arm of Pharmaron. Direct peer for ARC's custom synthesis business serving pharma ADME and metabolism studies.
  • ABX Advanced Biochemical Compounds: German manufacturer of radioactive and stable isotope-labeled compounds for medical and research use. Comparable to ARC as a specialized radiochemical supplier with similar isotope coverage.
  • Moravek Biochemicals: US-based manufacturer of radiolabeled compounds (Carbon-14, Tritium) for life science research, with custom synthesis services. Directly competes with ARC in catalog breadth and target customer base.
  • Vitrax Corporation: Specialty manufacturer of radiolabeled chemicals and stable isotope-labeled compounds for research. Closely comparable to ARC in product category, scale, and research customer focus.

Emerging players

  • IsoTherapeutics Group: Specialty radiochemistry contract manufacturer focused on custom radiolabeled compounds and radiopharmaceutical development. Comparable as a niche, custom-synthesis-oriented peer.
  • Telix Pharmaceuticals: Growing radiopharmaceutical company with expanding isotope and therapeutic capabilities. Comparable as a participant in the broader nuclear-medicine value chain, though focused on clinical rather than research use.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

American Radiolabeled Chemicals social profiles

Digital presence

American Radiolabeled Chemicals financial estimates

Financial estimate

Revenue estimate

Valuation estimate

American Radiolabeled Chemicals leadership team

Management profile

Number of profiles

American Radiolabeled Chemicals subsidiaries and ownership

Company hierarchy

Subsidiaries2 records

American Radiolabeled Chemicals funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

American Radiolabeled Chemicals M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about American Radiolabeled Chemicals

What does American Radiolabeled Chemicals do?

ARC manufactures and supplies radiolabeled and unlabeled chemicals—predominantly Carbon-14 and Tritium (Hydrogen-3) labeled compounds, plus other radioisotopes such as Phosphorus-32/33, Sulfur-35, Iodine-125, Chlorine-36, Chromium-51, Calcium-45, Iron-55/59, Sodium-22, Strontium-85, and Zinc-65—alongside stable isotopes, unlabeled reference compounds, and autoradiography standards for life science research. The company complements its catalog of 4,000+ compounds with custom radiochemical synthesis services utilizing Carbon-14 and Tritium, with limited basis support for Phosphorus-33, Sulfur-35, and selected stable isotopes.

Is American Radiolabeled Chemicals a public or private company?

American Radiolabeled Chemicals is a private company. It is classified as unknown and is currently operating.

When was American Radiolabeled Chemicals founded?

American Radiolabeled Chemicals was founded in 1983. It employs 11 to 50 people.

Where is American Radiolabeled Chemicals based?

American Radiolabeled Chemicals is headquartered in St Louis, United States, in the North America region.

How does American Radiolabeled Chemicals make money?

Three revenue lines are on record. Radiolabeled Compound Sales are the primary driver. The others are custom Synthesis Services and unlabeled Compound Sales.

Who are American Radiolabeled Chemicals's main competitors?

Broad incumbents on record are Curium Pharma, Revvity (formerly PerkinElmer Life Sciences), Lantheus Holdings and GE HealthCare / Cytiva. Direct peers are Quotient Bioresearch (Pharmaron Radiolabeled Chemistry), ABX Advanced Biochemical Compounds, Moravek Biochemicals and Vitrax Corporation. Emerging players are IsoTherapeutics Group and Telix Pharmaceuticals.

Does American Radiolabeled Chemicals have an API?

No public API is recorded for American Radiolabeled Chemicals.

What industry is American Radiolabeled Chemicals in?

American Radiolabeled Chemicals's product category is Radiolabeled Chemicals & Radiochemical Reagents. Its primary akta.pro industry code is HLAIAGAD, Radioisotope Production (Reactor/Cyclotron/Gamma). Its NAICS code is 325413 and its SIC code is 2800.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales